7.09

8.98% 0.5844

Tevogen Bio Holdings Inc (TVGN)

Overview News Price History Financials Discussions Forecast Stock Split

Tevogen Bio Holdings Inc stock is traded at $7.09, with a volume of 570. It is up +8.98% in the last 24 hours and down -8.52% over the past month. Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. The first clinical product of ExacTcell, TVGN 489, is initially being developed to fill a critical gap in COVID-19 therapeutics for the immunocompromised and the high-risk elderly, with potential applications in both treatment and prevention of chronic, lingering symptoms of the disease (Long COVID). Viruses, including COVID-19, hijack cellular machinery to transform infected cells into virus production plants.

Previous Close:

$6.5056

Open:

$6.38

24h Volume:

570

Relative Volume:

0.10

Market Cap:

$46.17M

Revenue:

Net Income/Loss:

$-26.28M

P/E Ratio:

-1.653

EPS:

-4.2891

Net Cash Flow:

$-12.39M

1W Performance:

+0.42%

1M Performance:

-8.52%

6M Performance:

+10.09%

1Y Performance:

-81.21%

1-Day Range:

$6.38

$7.09

1-Week Range:

$6.38

$7.15

52-Week Range:

$3.6364

$39.00

Tevogen Bio Holdings Inc Stock (TVGN) Company Profile

Name

Tevogen Bio Holdings Inc

Sector

Healthcare (1051)

Industry

Biotechnology (593)

Phone

646-807-8832

Address

15 INDEPENDENCE BOULEVARD, SUITE #210, WARREN

Employee

Twitter

Next Earnings Date

2026-11-13

Latest SEC Filings

TVGN's Discussions on Twitter

Compare TVGN vs VRTX, MRNA, REGN, ARGX, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TVGN Tevogen Bio Holdings Inc	7.09	46.17M	0	-26.28M	-12.39M	-4.2891
VRTX Vertex Pharmaceuticals Inc	508.74	128.95B	12.34B	4.34B	3.71B	16.87
MRNA Moderna Inc	236.50	94.42B	2.23B	-3.19B	-1.60B	-8.1462
REGN Regeneron Pharmaceuticals Inc	796.35	81.99B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	846.50	53.23B	4.16B	1.29B	734.26M	19.58
ONC Beone Medicines Ltd Adr	374.30	42.34B	5.76B	514.49M	1.10B	4.4813

Tevogen Bio Holdings Inc Stock (TVGN) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-04-26	Downgrade	D. Boral Capital	Buy → Hold
Mar-04-25	Initiated	D. Boral Capital	Buy

Tevogen Bio Holdings Inc Stock (TVGN) Latest News

Sep 30, 2026

Nasdaq issues a decision on the $50M listing requirement for Tevogen (NASDAQ: TVGN). - Stock Titan

Sep 30, 2026

Sep 21, 2026

Tevogen Bio grants major performance-based executive stock awards - TipRanks

Sep 21, 2026

Sep 16, 2026

A $1 billion sales goal now decides whether a Tevogen Inc. (TVGN) insider keeps 750K shares - Stock Titan

Sep 16, 2026

Tevogen (Nasdaq: TVGN) conditions CEO's 8M-share award on a $1 billion revenue hurdle - Stock Titan

Sep 16, 2026

PODLOGAR SUSAN M Awarded 75,000 Shares of Tevogen Inc. in Director Grant - Kalkine Media

Sep 16, 2026

Patton Curtis L. Awarded 75,000 Shares of Tevogen Inc., Increasing Holdings to 139,192 Shares - Kalkine Media

Sep 16, 2026

Sep 15, 2026

Tevogen Inc. (NASDAQ: TVGN) awards 75,000-share stock grant to director - Stock Titan

Sep 15, 2026

Sep 10, 2026

Form 8K Tevogen Bio Holdings Inc For: 10 September By Investing.com - Investing.com Nigeria

Sep 10, 2026

Form 8K Tevogen Bio Holdings Inc For: 10 September By Investing.com - Investing.com Canada

Sep 10, 2026

Tevogen regains Nasdaq compliance with minimum market value requirement - Investing.com

Sep 10, 2026

Form 8K Tevogen Bio Holdings Inc For: 10 September By Investing.com - Investing.com India

Sep 10, 2026

Tevogen regains Nasdaq compliance with minimum market value requirement By Investing.com - Investing.com UK

Sep 10, 2026

Tevogen Bio regains Nasdaq listing compliance status - TipRanks

Sep 10, 2026

Tevogen (Nasdaq: TVGN) back in line with $15M Nasdaq rule - Stock Titan

Sep 10, 2026

Sep 01, 2026

Tevogen Bio Holdings (TVGN) Holds Near $7 as Biotech Stock Consolidates Between Support and ResistanceFundamental Weighted - dars.gov.et

Sep 01, 2026

Tevogen Bio Holdings (TVGN) Holds Near $7 as Biotech Stock Consolidates Between Support and ResistanceBuffered ETF - dars.gov.et

Sep 01, 2026

Aug 31, 2026

Tevogen Bio (TVGN) Rises to $6.98 as Resistance at $7.33 Comes Into FocusExhaustion Gap - vinanet.vn

Aug 31, 2026

Aug 26, 2026

Tevogen (TVGN) adds 100M to equity plan, OKs written consent - Stock Titan

Aug 26, 2026

Aug 17, 2026

Tevogen Bio Holdings (TVGN) Q4 2025 Earnings: Narrower-Than-Expected Loss Drives 4.57% Share GainSubscription Growth Report - vinanet.vn

Aug 17, 2026

Tevogen Bio Holdings (TVGN) Q4 2025 Earnings: Narrower-Than-Expected Loss Drives 4.57% Share GainEPS Estimate Trend - dars.gov.et

Aug 17, 2026

Aug 16, 2026

TVGN Q4 2025 Earnings: Narrower-Than-Expected Loss Signals Improved Cost Discipline for Clinical-Stage Biotech - vinanet.vn

Aug 16, 2026

Aug 14, 2026

Tevogen Inc (TVGN) narrows first-half loss amid tight cash and heavy R&D - Stock Titan

Aug 14, 2026

Tevogen Bio Holdings Inc. (NASDAQ: TVGN) Share Price, TVGN Stock News, TVGN Share Price & Updates - Kalkine

Aug 14, 2026

Aug 08, 2026

TVGN Q4 2025 Earnings: Narrower-than-Expected Loss Highlights Pre-Revenue StageEPS Consistency Score - vinanet.vn

Aug 08, 2026

Aug 07, 2026

TVGN Q4 2025 Earnings: Narrower-Than-Expected Loss Highlights Cost Discipline at Pre-Revenue BiotechMargin Expansion Trends - vinanet.vn

Aug 07, 2026

Aug 06, 2026